Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (5): 453-457.doi: 10.3736/jcim20100509

• Original Experimental Research • Previous Articles     Next Articles

Effects of Fufang Jiangzhi No.3 on cholesterol-bile acid metabolism in rabbits with hypercholesterolemia

 Qi-qi Maoa, Xu Suna, Dong-ni Qiua, Xiao-dong Fub, Yi Liua, Wen-jian Wangb   

  1. a Department of Gastroenterology, Huashan Hospital, Fudan University, Shanghai 200040, China
    b Department of Traditional Chinese Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Received:2010-01-08 Accepted:2010-03-25 Online:2010-05-20 Published:2010-05-15
  • Contact: Xu Sun


To investigate the effects of Fufang Jiangzhi No. 3, a compound traditional Chinese herbal medicine, on cholesterol-bile acid metabolism in rabbits with hypercholesterolemia and to explore the mechanism.

Twenty-four male New Zealand white rabbits were randomly assigned into normal control group, untreated group and Fufang Jiangzhi No. 3 group, with 8 rabbits in each group. Rabbits in the untreated group and Fufang Jiangzhi No. 3 group were fed high cholesterol diet to induce hypercholesterolemia. After 4-week treatment, serum total cholesterol and bile acid contents were assessed. Activity of cholesterol 7α-hydroxylase (CYP7A1) in liver tissues was measured by enzyme-linked immunosorbent assay. The expressions of CYP7A1, bile salt export pump (BSEP) and small heterodimer partner (SHP) mRNAs in liver tissues were observed by real-time fluorescent quantitative polymerase chain reaction.

Compared with the normal control group, serum total cholesterol and bile acid contents in the untreated group were increased (P<0.01). Activity of CYP7A1 and expression of CYP7A1 mRNA were decreased and expressions of BSEP and SHP mRNAs were increased in liver tissues in the untreated group as compared with the normal control group (P<0.01). Serum total cholesterol level, and expressions of BSEP and SHP mRNAs in the Fufang Jiangzhi No. 3 group were lower than those in the untreated group (P<0.01). The CYP7A1 activity and expression of CYP7A1 mRNA in the Fufang Jiangzhi No. 3 group were increased as compared with the untreated group (P<0.01), however, there was no significant difference in bile acid between the Fufang Jiangzhi No. 3 group and the untreated group.

Fufang Jiangzhi No. 3 can up-regulate the expression of CYP7A1 mRNA, raise the activity of CYP7A1, and inhibit the expressions of BSEP and SHP mRNAs to regulate the metabolism of total cholesterol in rabbits.

Key words: Bile acid, Cholesterol, Chinese medical formula, Farnesoid X receptor, Cholesterol 7-alpha- hydroxylase, Bile salt export pump, Small heterodimer partner receptor, Rabbits

Table 1

Forward and reverse primers used for real-time fluorescent quantitative PCR"

Gene Primer Length of product (bp)

Table 2

Levels of serum total cholesterol and bile acid in different groups (x±s)"

Group n Total cholesterol (mmol/L) Bile acid (jumol/L)
Normal control 8 4. 51±0. 45 7. 45±1.33
Untreated 8 23. 14±3. 21* * 13. 95±1. 86〃
Compound No. 3 8 16.21±2.14**AA 13.31±1.27* *

Table 3

Concentration of CYP7A1 and expression of CYP7A1 mRNA in different groups (x±s)"

Group Concentration of n , CYP7A1 mRNA
CYP7A1 (pg/mL)
Normal control 8 0. 80±0. 22 1. 97±1. 50
Untreated 8 0. 44±0. 16** 0. 70±0. 27〃
Compound No. 3 8 0. 81±0. 21AA 3. 87±1. 68**aa

Table 4

Expressions of BSEP and SHP mRNAs in different groups (x±s)"

Normal control 8 9. 83±2. 50 7. 33±2. 44
Untreated 8 85. 44±6. 79〃 16. 40±3. 01〃
Compound No. 3 8 20. 73±4. 9. 64±1. 63**AA
[1] Shibata S, Hayakawa K, Egashira Y, Sanada H . Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats[J]. Life Sci, 2007,80(6):546-553
doi: 10.1016/j.lfs.2006.10.003
[2] Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ . Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis[J]. Cell, 2000,102(6):731-744
doi: 10.1016/S0092-8674(00)00062-3
[3] Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ . Molecular basis for feedback regulation of bile acid synjournal by nuclear receptors[J]. Mol Cell, 2000,6(3):507-515
doi: 10.1016/S1097-2765(00)00050-2
[4] Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ . Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor[J]. J Biol Chem, 2001,276(31):28857-28865
doi: 10.1074/jbc.M011610200
[5] Goodwin B, Jones SA, Price RR, Watson MA , McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA .A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynjournal[J]. Mol Cell, 2000,6(3):517-526
doi: 10.1016/S1097-2765(00)00051-4
[6] Xu G, Li H, Pan LX, Shang Q, Honda A, Ananthanarayanan M, Erickson SK, Shneider BL, Shefer S, Bollineni J, Forman BM, Matsuzaki Y, Suchy FJ, Tint GS, Salen G . FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbits[J]. J Lipid Res, 2003,44(10):1956-1962
doi: 10.1194/jlr.M300182-JLR200
[7] Tu H, Okamoto AY, Shan B . FXR, a bile acid receptor and biological sensor[J]. Trends Cardiovasc Med, 2000,10(1):30-35
doi: 10.1016/S1050-1738(00)00043-8
[8] Chiang JY . Bile acid regulation of gene expression: roles of nuclear hormone receptors[J]. Endocr Rev, 2002,23(4):443-463
doi: 10.1210/er.2000-0035
[9] Suzuki T, Tamehiro N, Sato Y, Kobayashi T, Ishii-Watabe A, Shinozaki Y, Nishimaki-Mogami T, Hashimoto T, Asakawa Y, Inoue K, Ohno Y, Yamaguchi T, Kawanishi T . The novel compounds that activate farnesoid X receptor: the diversity of their effects on gene expression[J]. J Pharmacol Sci, 2008,107(3):285-294
doi: 10.1254/jphs.08006FP
[10] Wang YD, Chen WD, Moore DD, Huang WD . FXR: a metabolic regulator and cell protector[J]. Cell Res, 2008,18(11):1087-1095
doi: 10.1038/cr.2008.289
[1] Morad Hebi, Mohamed Eddouks. Hypolipidemic activity of Tamarix articulata Vahl. in diabetic rats. Journal of Integrative Medicine, 2017, 15(6): 476-482.
[2] Keshav Raj Paudel, Ung-Won Lee, Dong-Wook Kim. Chungtaejeon, a Korean fermented tea, prevents the risk of atherosclerosis in rats fed a high-fat atherogenic diet. Journal of Integrative Medicine, 2016, 14(2): 134-142.
[3] Cheng Huang​. Natural modulators of liver X receptors. Journal of Integrative Medicine, 2014, 12(2): 76-85.
[4] Gang Guo, Jian-hua Xu, Jian-hong Han, Fang Liang, Yong Zhang, Qiang Zhang, Jue Sun, Zhong-ze Fan . Chinese herbal decoction Shiquan Dabu Tang inhibits tumor growth and angiogenesis of metastasis after primary tumor surgical removal in mice. Journal of Chinese Integrative Medicine, 2012, 10(4): 436-447.
[5] Yong-an Li, Xiao-ling Lu. Translation techniques for explanations of traditional Chinese medicine formula. Journal of Chinese Integrative Medicine, 2011, 9(2): 229-232.
[6] Bing Hu, Hong-mei An, Ke-ping Shen, Qin Du. Effects of Tenglong Buzhong Decoction on proliferation and apoptosis of human colon carcinoma cell line LS174T. Journal of Chinese Integrative Medicine, 2010, 8(6): 575-580.
[7] Hui Qiang, Kun-zheng Wang, Chen Zhang, Zhi-bin Shi, Li-hong Fan. Panax notoginseng saponins protect rabbit bone marrow stromal cells from hydrogen peroxide-induced apoptosis. Journal of Chinese Integrative Medicine, 2010, 8(2): 131-137.
[8] Bin Cheng, Xin Wang, Lei Wang, Kai Cao, Lei Duan, Feng-tao Li. Changes of mitochondrial apoptosis in spinal cord ischemia-reperfusion injury and the effects of Herba Erigerontis Breviscapi Injection preconditioning intervention in rabbits. Journal of Chinese Integrative Medicine, 2009, 7(9): 842-847.
[9] Marjan Nassirl-Asl, Farzaneh Zamansoltiani, Esmail Abbasl, Mohammad-Mehdi Daneshi, Amir-Abdollah Zangivand. Effects of Urtica dioica extract on lipid profile in hypercholesterolemic rats. Journal of Chinese Integrative Medicine, 2009, 7(5): 428-433.
[10] Ling-hui Dai, Yong Xu, Yan-hao Xiong, Feng Gao, Jiong Hu, Ning Du. Effects of manipulation therapy in repairing rabbit articular cartilage defects. Journal of Chinese Integrative Medicine, 2009, 7(4): 372-378.
[11] Qi Liang, Ming Xie . Analysis of toxicity of traditional Chinese herbal medicine and its connotation. Journal of Chinese Integrative Medicine, 2009, 7(2): 101-104.
[12] Xue Yang , Wen-bo Peng , Xiao-qiang Yue. Syndrome differentiation and treatment of Taiyang disease in Shanghan Lun. Journal of Chinese Integrative Medicine, 2009, 7(2): 171-174.
[13] You-xue Chen, Guo-ping Li, Hong-en Yao, Su-fan Li, Li-gong Duan. Bushen Jianpi Huoxue Recipe in prevention and treatment of tibial stress injuries in rabbits. Journal of Chinese Integrative Medicine, 2008, 6(7): 738-743.
[14] GD Zhao, KJ Gao, YM Tian, ZW Ye, W Li, HP Song, ZY Cai. Experimental study of Gukangling Decoction combined with technetium [99Tc] methylene diphosphonate injection in treating osteoporotic rabbits. Journal of Chinese Integrative Medicine, 2008, 6(3): 298-303.
[15] Fu-guo Yang, An-yong Zhang, Zuo-yuan Chen, Zhe-xun Chen, Ge-xin Liu, Guo-xiong Dong. Effects of salvianolic acid B on cardiovascular endothelial cells and platelet activation in a rabbit model of ischemia-reperfusion. Journal of Chinese Integrative Medicine, 2008, 6(12): 1250-1254.
Full text



[1] Jun Zheng, Jian Zheng, Pei-yong Zheng. Application of quality of life scale in evaluating the efficacy of gastric cancer treatment. Journal of Chinese Integrative Medicine, 2008, 6(3): 304-310
[2] Jian-ping Liu. Design, implementation and methodological issues in cohort study. Journal of Chinese Integrative Medicine, 2008, 6(4): 331-335
[3] Xun Li, Jian-ping Liu. Chinese medicinal herbs for chronic hepatitis B. Journal of Chinese Integrative Medicine, 2008, 6(4): 336
[4] Jun-hua Zhang, Hong-cai Shang, Bo-li Zhang. How to assess the quality of systematic review and meta-analysis. Journal of Chinese Integrative Medicine, 2008, 6(4): 337-339
[5] Fan Yin . The first acupuncture center in the United States: An interview with Dr. Yao Wu Lee, Washington Acupuncture Center. Journal of Chinese Integrative Medicine, 2012, 10(5): 481-492
[6] Daniel A. Weber, Janelle M. Wheat , Geoffrey M. Currie. Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: A review. Journal of Chinese Integrative Medicine, 2012, 10(5): 493-503
[7] Liang-ping Hu, Xiao-lei Bao. How to choose an appropriate experimental design type (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(6): 615-618
[8] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634
[9] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640
[10] Peng Fu , Xue-qiang Huang, Ai-hong Yuan, Guang Yu, Xiao-bin Mei, Ruo-lan Cu. Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 641-646